Live News REGULATION FLASH L impact Nov 05, 2026, 04:02 AM UTC SSY Group’s Sustained-Release Tofacitinib Tablets Approved The tablets were approved for rheumatoid arthritis and related conditions. GROUP SquawkNews Desk